Zauatbayeva, G. ., Syzdykova , L., Keyer , V. ., Shustov , A., Abilmagzhanov , A. and Zhurynov , M. (2022) “NUCLEOSIDE ANALOG FAVIPIRAVIR IS A POOR INHIBITOR AGAINST THE SARS-COV-2 VIRUS IN CELL CULTURE, BUT FAVIPIRAVIR IS HIGHLY ACTIVE AGAINST VENEZUELAN EQUINE ENCEPHALITIS VIRUS”, Eurasian Journal of Applied Biotechnology, (2), pp. 44–53. doi: 10.11134/btp.2.2022.7.